⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Pediatric Long-Term Follow-up and Rollover Study

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study Description

Brief Summary: A roll-over study to assess long-term effect in pediatric patients treated with dabrafenib and/or trametinib.

Detailed Description:

Eligibility

Minimum Age: 1 Year

Eligible Ages: CHILD, ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Phoenix Children's Hospital ., Phoenix, Arizona, United States

Childrens National Hospital CQTI571A2306, Washington, District of Columbia, United States

Nicklaus Childrens Hospital, Miami, Florida, United States

Indiana Uni School of Medicine ., Indianapolis, Indiana, United States

Johns Hopkins University IDS Pharmacy, Baltimore, Maryland, United States

Dana Farber Cancer Institute ., Boston, Massachusetts, United States

University of Minnesota ., Minneapolis, Minnesota, United States

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Cinn Children Hosp Medical Center, Cincinnati, Ohio, United States

St Jude Childrens Research Hospital ., Memphis, Tennessee, United States

Texas Children's Hospital, Houston, Texas, United States

Novartis Investigative Site, Caba, Buenos Aires, Argentina

Novartis Investigative Site, Darlinghurst, New South Wales, Australia

Novartis Investigative Site, Parkville, Victoria, Australia

Novartis Investigative Site, Bruxelles, , Belgium

Novartis Investigative Site, Barretos, SP, Brazil

Novartis Investigative Site, Sao Paulo, SP, Brazil

Novartis Investigative Site, Sao Paulo, SP, Brazil

Novartis Investigative Site, Vancouver, British Columbia, Canada

Novartis Investigative Site, Toronto, Ontario, Canada

Novartis Investigative Site, Montreal, Quebec, Canada

Novartis Investigative Site, Brno, , Czechia

Novartis Investigative Site, Praha 5, , Czechia

Novartis Investigative Site, Copenhagen, , Denmark

Novartis Investigative Site, Tampere, , Finland

Novartis Investigative Site, Rennes, Bretagne, France

Novartis Investigative Site, Brest Cedex, Finistere, France

Novartis Investigative Site, Marseille Cedex 05, , France

Novartis Investigative Site, Paris, , France

Novartis Investigative Site, Vandoeuvre Les Nancy, , France

Novartis Investigative Site, Villejuif, , France

Novartis Investigative Site, Augsburg, , Germany

Novartis Investigative Site, Berlin, , Germany

Novartis Investigative Site, Essen, , Germany

Novartis Investigative Site, Hamburg, , Germany

Novartis Investigative Site, Koeln, , Germany

Novartis Investigative Site, Petach-Tikva, , Israel

Novartis Investigative Site, Firenze, FI, Italy

Novartis Investigative Site, Genova, GE, Italy

Novartis Investigative Site, Milano, MI, Italy

Novartis Investigative Site, Roma, RM, Italy

Novartis Investigative Site, Torino, TO, Italy

Novartis Investigative Site, Setagaya-ku, Tokyo, Japan

Novartis Investigative Site, Osaka, , Japan

Novartis Investigative Site, Utrecht, CS, Netherlands

Novartis Investigative Site, Moscow, , Russian Federation

Novartis Investigative Site, Madrid, , Spain

Novartis Investigative Site, Valencia, , Spain

Novartis Investigative Site, Stockholm, , Sweden

Novartis Investigative Site, Sutton, Surrey, United Kingdom

Novartis Investigative Site, Liverpool, , United Kingdom

Novartis Investigative Site, London, , United Kingdom

Novartis Investigative Site, London, , United Kingdom

Contact Details

Name: Novartis Pharmaceuticals

Affiliation: Novartis Pharmaceuticals

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: